Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bug, G
  • Burchert, A
  • Wagner, E-M
  • Kröger, N
  • Berg, Tobias
  • Güller, S
  • Metzelder, SK
  • Wolf, A
  • Hünecke, S
  • Bader, P
  • Schetelig, J
  • Serve, H
  • Ottmann, OG

publication date

  • November 2017